AXSOME THERAPEUTICS INC. - COMMON STOCK

Axsome Therapeutics Announces Results of the SUPPORT Survey of Patients with Major Depressive Disorder Presented at the American Society of Clinical Psychopharmacology Association (ASCP) 2022 Annual Meeting

06 6 2022 07:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder

02 6 2022 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology (ASCP) 2022 Annual Meeting

01 6 2022 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry

31 5 2022 07:39:37 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

09 5 2022 08:57:19 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience

28 3 2022 06:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Participate in the 1st Annual Needham Virtual Neuroscience Forum

11 3 2022 07:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference

02 3 2022 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

01 3 2022 07:00:02 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

15 2 2022 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 2 2022 07:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update

08 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021

20 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million

18 10 2021 07:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy

16 9 2021 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine

14 9 2021 07:00:01 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder

23 8 2021 06:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

09 8 2021 07:05:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics to Report Second Quarter 2021 Financial Results on August 9, 2021

15 7 2021 07:00:00 提供 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia

15 6 2021 07:00:01 提供 Nasdaq GlobeNewswire